Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Liver Cirrhosis

  Free Subscription


17.08.2026

2 BMC Gastroenterol
3 Clin Res Hepatol Gastroenterol
1 J Gastroenterol
1 J Hepatol
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Gastroenterol

  1. RAMADAN AM, El-Wakeel LM, Adel A, Abdel-Wahab M, et al
    Effect of high dose N-acetyl cysteine supplementation on markers of oxidative stress and insulin resistance in non-diabetic patients with metabolic dysfunction associated steatotic liver disease: a randomized controlled trial.
    BMC Gastroenterol. 2026;26:500.
    PubMed         Abstract available

  2. WU X, Hou X, Yin J, Li Y, et al
    Association of a novel Fat-Muscle-BMI Index (FMBI) with NAFLD, liver fibrosis, and atherosclerotic cardiovascular disease risk: a cross-sectional study in 1,592 Chinese adults.
    BMC Gastroenterol. 2026;26:501.
    PubMed         Abstract available


    Clin Res Hepatol Gastroenterol

  3. YAGNIK N
    Interpreting the Global Burden of Multidrug Resistance in Hospitalized Patients with Cirrhosis.
    Clin Res Hepatol Gastroenterol. 2026 Aug 13:102905.
    PubMed        

  4. JIANG T, Cui XP, Yin YS, Xu DQ, et al
    Management of Portal Vein Thrombosis in Cirrhosis: Risks, Treatments, and Outcomes of a Retrospective Multicenter Study With Over 10 Years of Follow-Up.
    Clin Res Hepatol Gastroenterol. 2026 Aug 13:102902.
    PubMed         Abstract available

  5. KALAL CR, Gupta P
    Reticulocalbin 3 in cirrhosis: liver biomarker or marker of systemic decompensation?
    Clin Res Hepatol Gastroenterol. 2026 Aug 10:102903.
    PubMed        


    J Gastroenterol

  6. ZHOU LX, Wan BY, Dong H, Shi AL, et al
    Reply to: comment on "Validation of Baveno VII criteria for recompensation in patients with decompensated cirrhosis treated by laparoscopic splenectomy and azygoportal disconnection".
    J Gastroenterol. 2026 Aug 10. doi: 10.1007/s00535-026-02497.
    PubMed        


    J Hepatol

  7. WELLS G, O'Brien A
    Non-selective Beta-Blockers in Cirrhosis and AKI: Time to Reconsider Routine Withdrawal?
    J Hepatol. 2026 Aug 13:S0168-8278(26)02848-5. doi: 10.1016/j.jhep.2026.
    PubMed        


    PLoS One

  8. FENG J, Liu Z, Sun H
    Integrative bioinformatics analysis identifies gut microbiota-derived metabolite-associated immune candidate targets in high-risk primary biliary cholangitis.
    PLoS One. 2026;21:e0356008.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum